Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer Paola UliviRosella Silvestrini Review 01 November 2013 Pages: 439 - 448
PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic Anne-Laure PapaAlmas SidiquiRania Harfouche Original Paper 01 October 2013 Pages: 449 - 457
Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole Akhilesh RawatGopisetty GopalThangarajan Rajkumar Original Paper 27 September 2013 Pages: 459 - 467
Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma Bartosz PulaMateusz OlbromskiMarzena Podhorska-Okolow Original Paper 25 September 2013 Pages: 469 - 483
Increase in ezrin expression from benign to malignant breast tumours Daphne Gschwantler-KaulichCamilla NatterChristian F. Singer Original Paper 16 October 2013 Pages: 485 - 491
Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway Jeong Su ParkSu Yun ChoiYoung Yang Original Paper 10 October 2013 Pages: 493 - 503
Macrophages as potential targets for zoledronic acid outside the skeleton—evidence from in vitro and in vivo models T. L. RogersN. WindI. Holen OriginalPaper 01 November 2013 Pages: 505 - 514
siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells Fatemeh BagheriShahrokh SafarianNader Sheibani Original Paper 26 November 2013 Pages: 515 - 526
